Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M, Hayashi M, Takemura S, Tanaka S, Nakata Y, Matsui K, Ishizaki M, Hirokawa F, Komeda K, Uchiyama K, Kon M, Doki Y, Mori M.
Wada H, et al. Among authors: takemura s.
Surg Today. 2018 Jan;48(1):73-79. doi: 10.1007/s00595-017-1553-3. Epub 2017 Jun 8.
Surg Today. 2018.
PMID: 28597349